TG Therapeutics, Inc.
TG Therapeutics, Inc. is a Private limited company (Ltd.) registered in United States under 1415479, and its current status with North Carolina Secretary of State is active. The company was incorporated on 8 December 2014 and lists its registered address as Morrisville, United States. 5 shareholders are on record for TG Therapeutics, Inc., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from North Carolina Secretary of State and was last updated on 3 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for TG Therapeutics, Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Blackrock Inc., holding 13.8% — the largest recorded stake — followed by Vanguard Group Inc at 10.1%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 16 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Blackrock Inc. | 13.8% | North Carolina Secretary of State | |
| Vanguard Group Inc | 10.1% | North Carolina Secretary of State | |
| State Street Corporation | 5.3% | North Carolina Secretary of State | |
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.1% | North Carolina Secretary of State | |
| ClearBridge Investments, LLC | 3% | North Carolina Secretary of State |
Officers
2
Two officers are currently on record for TG Therapeutics, Inc., filed with North Carolina Secretary of State. Michael Weiss serves as President; Sean Power serves as Secretary.
Management authority at TG Therapeutics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
TG Therapeutics, Inc. has no recorded parent company — it sits at the top of its own group structure, with 3 subsidiaries recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 3 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
TG Therapeutics, Inc.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns TG Therapeutics, Inc.?
Five shareholders are currently on record for TG Therapeutics, Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Blackrock Inc., holding 13.8% — the largest recorded stake — followed by Vanguard Group Inc at 10.1%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is TG Therapeutics, Inc.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for TG Therapeutics, Inc. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does TG Therapeutics, Inc. have on record?
5 shareholders are shown on record for TG Therapeutics, Inc.. The register reports 16 in total; only the top 5 by holding are shown here.
What is TG Therapeutics, Inc.'s company registration number?
TG Therapeutics, Inc.'s registration number is 1415479, filed with North Carolina Secretary of State in United States. Its current status on the register is active.
Is TG Therapeutics, Inc. still an active company?
TG Therapeutics, Inc.'s status on North Carolina Secretary of State is listed as active.
When was TG Therapeutics, Inc. incorporated?
TG Therapeutics, Inc. was incorporated on 8 December 2014, according to North Carolina Secretary of State.
What is TG Therapeutics, Inc.'s registered address?
The registered address on file for TG Therapeutics, Inc. is Morrisville, United States.
What legal structure is TG Therapeutics, Inc. registered as?
TG Therapeutics, Inc. is registered as a Private limited company (Ltd.) in United States.
Who are the officers/directors of TG Therapeutics, Inc.?
Two officers are currently on record for TG Therapeutics, Inc., filed with North Carolina Secretary of State. Michael Weiss serves as President; Sean Power serves as Secretary. Management authority at TG Therapeutics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does TG Therapeutics, Inc. have a parent company or subsidiaries?
TG Therapeutics, Inc. has no recorded parent company — it sits at the top of its own group structure, with 3 subsidiaries recorded beneath it across 1 jurisdiction. Those 3 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to TG Therapeutics, Inc.'s ownership over time?
This profile reflects a point-in-time snapshot from North Carolina Secretary of State. Zavia's monitoring API can track changes to TG Therapeutics, Inc.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access TG Therapeutics, Inc.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like TG Therapeutics, Inc.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from North Carolina Secretary of State and was last synced on 3 October 2026.